Kintor Pharmaceutical Limited
KNTPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $552 | $503 | $288 | $1 |
| - Cash | $53 | $147 | $323 | $445 |
| + Debt | $87 | $133 | $239 | $254 |
| Enterprise Value | $586 | $489 | $204 | -$191 |
| Revenue | $1 | $3 | $3 | $0 |
| % Growth | -67.3% | 0% | – | – |
| Gross Profit | -$2 | -$2 | -$2 | -$7 |
| % Margin | -214.8% | -94.6% | -94.6% | – |
| EBITDA | -$9 | -$64 | -$64 | -$1 |
| % Margin | -1,139.2% | -2,567.4% | -2,567.4% | – |
| Net Income | -$11 | -$78 | -$78 | -$1 |
| % Margin | -1,391.5% | -3,105.8% | -3,105.8% | – |
| EPS Diluted | -0.026 | -0.027 | -0.023 | -1.98 |
| % Growth | 2.6% | -17% | 98.8% | – |
| Operating Cash Flow | -$70 | -$88 | -$111 | -$0 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$70 | -$89 | -$111 | -$0 |